Links to the Summary of Product Characteristics (SmPC) and Patient Information Leaflets (PIL) for Novo Nordisk's range of diabetes products are available in this section.
NovoSeven® (eptacog alfa activated) | PIP Code |
NovoSeven® 1mg | 377-1672 |
NovoSeven® 2mg | 377-1680 |
NovoSeven® 5mg | 377-1698 |
NovoSeven® 8mg | 377-1760 |
Summary of Product Characteristics - Click here |
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0845 600 5055). Calls may be monitored for training purposes.
This
medicine is subject to additional safety monitoring. This will
allow quick identification of new safety information. You can help
by reporting any side effects you may get. See mhra.gov.uk/yellowcard for how to report side effects.
This page is intended for members of the UK public